MK0767 Glipizide Comparator Cardiac Safety Study

This study has been completed.

First Received on October 5, 2007. Last Updated on October 11, 2007 History of Changes

Sponsor:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00543010

Purpose

A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Condition	Intervention	Phase
Diabetes Mellitus, Type 2	Drug: MK0767	Phase III

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment

Resource links provided by NLM:

Genetics Home Reference related topics: 6q24-related transient neonatal diabetes mellitus

MedlinePlus related topics: Diabetes Diabetes Type 2

U.S. FDA Resources

Further study details as provided by Merck:

Study Start Date:	November 2002
Study Completion Date:	November 2004

Eligibility

Ages Eligible for Study:	21 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

You are taking at least one medication for high blood sugar
Age 21 to 80

Exclusion Criteria:

History of Type 1 Diabetes Mellitus
Currently on estrogen replacement therapy regimen
Currently on a weight loss program with ongoing weight loss or taking medications for weight loss
Having surgery 30 days before starting the study
Have taken any other investigational drug in the past 90 days
Have Hepatitis B or C
Active liver or gallbladder disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00543010

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00543010 History of Changes
Other Study ID Numbers:	2007_644
Study First Received:	October 5, 2007
Last Updated:	October 11, 2007
Health Authority:	United States: Food and Drug Administration

Additional relevant MeSH terms:

Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on February 09, 2012